Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LZTS2 anticorps (C-Term)

LZTS2 Reactivité: Humain WB, EIA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN953267
  • Antigène Voir toutes LZTS2 Anticorps
    LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
    Épitope
    • 10
    • 8
    • 6
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 571-601, C-Term
    Reactivité
    • 25
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 23
    • 2
    Lapin
    Clonalité
    • 25
    Polyclonal
    Conjugué
    • 15
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp LZTS2 est non-conjugé
    Application
    • 22
    • 15
    • 3
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Specificité
    This antibody recognizes Human LZTS2 (C-term).
    Purification
    Protein A column, followed by peptide affinity purification
    Immunogène
    KLH conjugated synthetic peptide between 571-601 amino acids from the C-terminal region of human LZTS2
    Isotype
    Ig Fraction
    Top Product
    Discover our top product LZTS2 Anticorps primaire
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.25 mg/mL
    Buffer
    PBS containing 0.09 % (W/V) Sodium Azide as preservative
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freezing and thawing.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Antigène
    LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
    Autre désignation
    LZTS2 (LZTS2 Produits)
    Synonymes
    anticorps lapser1, anticorps MGC89253, anticorps si:dkey-250a11.1, anticorps LAPSER1, anticorps BC014695, anticorps mKIAA1813, anticorps Lapser1, anticorps leucine zipper, putative tumor suppressor 2, anticorps leucine zipper tumor suppressor 2, anticorps leucine zipper, putative tumor suppressor 2a, anticorps leucine zipper, putative tumor suppressor 2 S homeolog, anticorps lzts2, anticorps LZTS2, anticorps lzts2a, anticorps Lzts2, anticorps lzts2.S
    Sujet
    Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.Synonyms: KIAA1813, LAPSER1, LZTS2, Leucine zipper putative tumor suppressor 2, hLZTS2
    Poids moléculaire
    72759 Da
    ID gène
    84445
    NCBI Accession
    NP_115805
Vous êtes ici:
Support technique